Special guest editor, Robert C. Wang, MD, is a fellowship trained expert in the diagnosis and treatment of uveitis. He practices at Texas Retina Associates, with 12 offices throughout the state. He can be reached via email at email@example.com.
Surgical placement of RETISERT® (fluocinolone acetonide intravitreal implant 0.59 mg, Bausch + Lomb)
Clinical trials and experience support the effectiveness of targeted intraocular therapy and management of side effects